Negotiations have begun once again with Dorevitch Pathology over rates of pay.

The company is facing significant problems in providing services due to the problems it is having in recruiting and retaining scientists. We are not surprised given the company’s refusal to pay to market rates.

Unless Dorevitch makes a reasonable offer to scientists and technicians it will continue to be unable to staff its laboratories adequately.